2023-09-12 11:44:12 ET
More on ADC Therapeutics
- Seeking Alpha’s Quant Rating on ADC Therapeutics
- Historical earnings data for ADC Therapeutics
- Financial information for ADC Therapeutics
- ADC Therapeutics: Slowly Moving Toward Solvency
- ADC Therapeutics SA ( ADCT ) Q2 2023 Earnings Call Transcript
- ADC Therapeutics SA 2023 Q2 - Results - Earnings Call Presentation
- ADC Therapeutics upgraded to neutral at JP Morgan on valuation
- ADC Therapeutics discontinues Zynlonta study over safety concerns
- Biggest stock movers today: Salesforce, Zillow Group, Iovance Biotherapeutics and more
- ADC Therapeutics falls after pausing mid-stage trial for lead asset
For further details see:
ADC Therapeutics tumbles after withdrawing 2023 revenue guidance